Eric Mull

Aryl Cyclopentadienyl Tricarbonyl Rhenium Complexes: Novel Ligands for the Estrogen Receptor with Potential Use as Estrogen Radiopharmaceuticals

Eric Mull, Viswajanani J. Sattigeri, Alice L. Rodriguez et al. · Bioorganic & Medicinal Chemistry · 2002 · 61 citations

Molecular Pharmacology, Medicinal Chemistry, Medicine +6

Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing

Li‐Qiang Sun, Eric Mull, Barbara Zheng et al. · Journal of Medicinal Chemistry · 2016 · 30 citations · Full text

Once-daily Dosing, Immunology, Pharmacotherapy +20

A versatile approach to the regioselective synthesis of diverse (−)-epicatechin-β-d-glucuronides

Eric Mull, M. Van Zandt, Adam Gołȩbiowski et al. · Tetrahedron Letters · 2012 · 25 citations

Diversity Oriented Synthesis, Biochemistry, Natural Sciences +7

Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors

Sharad Verma, Dhanapalan Nagarathnam, Jianxing Shao et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 23 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +9

Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Li‐Qiang Sun, Eric Mull, Stanley V. D’Andrea et al. · Journal of Medicinal Chemistry · 2020 · 22 citations · Full text